Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 103 clinical trials
Featured trial
A Phase IV, Multicenter, Open-Label Study of the Immunogenicity of Nutropin AQ® V1.1 [Somatropin (rDNA Origin) Injection] Administered Daily to Naive Growth Hormone-Deficient Children

A Phase IV, Multicenter, Open-Label Study of the Immunogenicity of Nutropin AQ® V1.1 [Somatropin (rDNA Origin) Injection] Administered Daily to Naive Growth Hormone-Deficient Children

  • 184 views
  • 25 Mar, 2021
  • 1 location
Featured trial
Natural History of MLIV

Natural History of MLIV

  • 104 views
  • 08 Nov, 2020
  • 1 location
Featured trial
Low Testosterone

Low Testosterone

  • 1646 views
  • 08 Nov, 2020
  • 1 location
Featured trial
Low Testosterone Replacement Therapy

This is a double-blind, placebo controlled, multicenter study of topical testosterone replacement therapy in symptomatic hypogonadal men with increased risk for cardiovascular disease. 

  • 17 views
  • 25 Jan, 2021
  • 1 location
None
Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children

This study evaluates the safety and efficiency of Pegylated Somatropin (PEG Somatropin) Injection in the treatment of endogenous growth hormone deficiency (GHD) in the broad population of

growth hormone
deficiency
stimulation test
somatropin
  • 7 views
  • 07 Nov, 2020
  • 1 location
None
A Non-inferiority Phase 2 Study to Evaluate the Safety and Efficacy of PEG-rhGH in the Treatment of AGHD

This study aims to explore the optimal dose of PEG-rhGH injection in the treatment of AGHD, preliminarily evaluate its safety and efficacy, to provide scientific and reliable evidence for the medication dosage in Phase 2 clinical study.

insulin
tolerance test
brain injury
pituitary hormone
glucocorticoids
  • 9 views
  • 21 Jan, 2021
  • 5 locations
None
A Study to Evaluating the Efficacy and Safety of Recombinant Long-acting Human Growth Hormone (TJ101) in Children With Growth Hormone Deficiency

A Phase III, Randomized, open-label, positive-drug parallel control, Study to Evaluate the Efficacy and Safety of TJ101 in Child subject with growth hormone deficieney.

  • 2 views
  • 14 Jul, 2021
  • 30 locations
None
A Research Study in Chinese Children With a Low Level of Hormone to Grow. Treatment is Somapacitan Once a Week Compared to Norditropin Once a Day.

The study compares 2 medicines for children who do not have enough hormone to grow: somapacitan given once a week (a new medicine) and Norditropin given once a day (the medicine doctors can already prescribe). Researchers will test to see how well somapacitan works. The study will also test if …

  • 0 views
  • 29 Nov, 2021
  • 18 locations
None
Phase 2 Study of LUM-201 in Children With Growth Hormone Deficiency (OraGrowtH210 Trial)

This is a multi-national trial. The goals of the trial are to study LUM-201 as a possible treatment for Pediatric Growth Hormone Deficiency (PGHD) and investigate a predictive enrichment marker

  • 0 views
  • 13 Nov, 2021
  • 49 locations
None
Investigating Efficacy and Safety of Once-weekly NNC0195-0092 (Somapacitan) Treatment Compared to Daily Growth Hormone Treatment (Norditropin FlexPro ) in Growth Hormone Treatment na ve Pre-pubertal Children With Growth Hormone Deficiency

(Norditropin FlexPro) in growth hormone treatment nave pre-pubertal children with growth hormone deficiency. The trial consists of a 26 week main trial period, followed by a 26 week extension trial

  • 44 views
  • 01 Dec, 2021
  • 57 locations